Replies to post #11803 on Biotech Values

[io_io]

Dew, or anyone:

re: GTCB

"Based on prevailing estimates, there are approximately 80,000 people in the European Union and 60,000 people in the US with HD. "

Still don't undersand why, with this prevalence, they allow such small trials for approval purposes ?

(I don't think the disteinction is "heredity" - no ?)